Cloned gene from sea animal may prove key in cancer drug development

December 10, 2004

Researchers at Scripps Institution of Oceanography at the University of California, San Diego, and their colleagues have taken a significant step forward in developing a new method to produce drug compounds with potential to treat various types of cancer.

In the current issue of the journal Chemistry and Biology, scientists at Scripps, the University of Minnesota and the Life Sciences Institute describe the development of "bryA," a gene that could help solve problems associated with the production of anticancer agents originally discovered in the marine invertebrate Bugula neritina.

"To be able to show that this gene really exists has been the Holy Grail for the last 10 years," said Scripps Professor Margo Haygood, a coauthor of the paper. "This takes us beyond just suspecting that a bacteria might be involved to actually having a gene that looks like the right thing."

Certain marine invertebrates such as Bugula neritina, a brown bryozoan animal with stringy tufts, live in a symbiotic relationship with bacteria that act as a chemical defense mechanism for the host animal.

In 2001, Haygood and other scientists in her Scripps laboratory found that such bacteria living in Bugula neritina were the source of bryostatins, a family of chemical compounds being closely studied for their potential as anticancer pharmaceuticals in leukemia, lymphoma and several cancers including colon, breast, ovarian and prostate.

One of the main obstacles impeding widespread bryostatin production is lack of a practical and economically viable method of producing the compounds. The bacteria cannot be grown in laboratories. And collecting vast numbers of the animals at sea would be environmentally destructive.

One way of solving this dilemma is to clone the genes involved in natural bryostatin development. In the Chemistry and Biology paper, the researchers describe the process by which they cloned a large complex of genes and singled out bryA, a gene for a catalyst the authors propose is active in bryostatin biosynthesis.

The researchers say it appears that bryA may synthesize a portion of the pharmacologically active component of bryostatin and therefore may be useful in developing clinically useful bryostatin byproducts.

"The isolation of bryA represents a significant step forward inunderstanding bryostatin biosynthesis and eventually harnessing bry genes to produce bryostatins and derivatives inexpensively and in abundant quantities," the authors write in the paper, one of the first studies that describes such a cloning achievement from a marine symbiont organism.

Haygood and members of her laboratory are now moving the research forward by attempting to use bryA to extract laboratory-developed bryostatin compounds.

Most cancer drugs work by killing rapidly growing cells, in many cases interfering with the body's normal processes. Bryostatin seems to be effective by "flipping a switch" that controls how cells behave in the body. In the case of leukemia, for example, it seems to bring the cells "to their senses" and make them behave like normal blood cells.

In addition to Haygood, research coauthors include Mark Hildebrand, Laura Waggoner, Sebastian Sudek, Scott Allen and Christine Anderson of Scripps; and Haibin Liu and David H. Sherman of the Life Sciences Institute (Sherman was formerly at the University of Minnesota). Haygood is a member of Scripps's Marine Biology Research Division and Center for Marine Biotechnology and Biomedicine and the Rebecca and John Moores UCSD Cancer Center.
-end-
The research was supported by the National Institutes of Health and the Department of Defense.

Scripps Institution of Oceanography on the web: http://scripps.ucsd.edu

Scripps News on the web: http://scrippsnews.ucsd.edu

Scripps Institution of Oceanography, at the University of California, San Diego, is one of the oldest, largest, and most important centers for global science research and graduate training in the world. The National Research Council has ranked Scripps first in faculty quality among oceanography programs nationwide. Now in its second century of discovery, the scientific scope of the institution has grown to include biological, physical, chemical, geological, geophysical, and atmospheric studies of the earth as a system. Hundreds of research programs covering a wide range of scientific areas are under way today in 65 countries. The institution has a staff of about 1,300, and annual expenditures of approximately $140 million from federal, state, and private sources. Scripps operates one of the largest U.S. academic fleets with four oceanographic research ships and one research platform for worldwide exploration.

University of California - San Diego

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.